[VIEW] agent=Pharmacy Informatics Lead | scenario_id=107 | rounds=20

--- Round 0 ---
[R0.1] Quality & Patient Safety Director (speak, public): As we consider the 60-day corrective action plan for improving our inpatient medication reconciliation processes, I want to emphasize the importance of aligning our efforts with the Joint Commission requirements. We have 45 days to demonstrate compliance, and our current baseline audit shows that only 71% of admission reconciliations and 62% of discharge reconciliations are being completed within the expected timeframes. Additionally, the top contributors to our medication errors are unclear ownership and after-hours admissions. I would like to discuss how we can ensure that this plan balances patient safety with our operational capabilities and budget constraints. What are your thoughts on the potential resource and training needs for this initiative?
[R0.2] Pharmacy Informatics Lead (speak, public): To effectively balance patient safety with our operational capabilities and budget constraints, I recommend we analyze the current medication reconciliation workflow. We currently have a 6-step process where pharmacist verification averages 18 minutes per patient. We should consider the proposed EHR workflow change, which includes a 'Reconcile and Sign' hard-stop at discharge, requiring an estimated build effort of 120 hours and a testing cycle of 2 weeks. Additionally, we will need to implement a microlearning training module of about 15 minutes for our target audience of 850 learners to ensure everyone is well-equipped. What are your thoughts on these proposals?
[R0.3] Hospital Finance & Operations Director (speak, public): I appreciate the insights on the current workflow and the proposed EHR changes. To effectively evaluate the financial and operational viability of this corrective action plan, we should also consider the cost implications of the proposed training and implementation efforts. Specifically, we need to estimate the total one-time cost for the remediation, including potential staffing backfill. Can we quantify the resource allocation required for the training module and the impact on our budget? Additionally, are there any anticipated operational strain indicators we should be aware of that could affect execution risk?

--- Round 1 ---
[R1.1] Quality & Patient Safety Director (speak, public): Thank you for your insights on the workflow and financial implications. To ensure we have a comprehensive understanding, could we estimate the total one-time costs associated with the training module and implementation, including any necessary staffing backfills? Additionally, are there any existing operational strain indicators we should consider that might impact our execution risk? This will help us gauge the feasibility of the corrective action plan while aligning with our patient safety objectives.
[R1.2] Pharmacy Informatics Lead (speak, public): In response to your question about estimating the total one-time costs for the training module and implementation, we can start by calculating the cost of the microlearning training for 850 learners, which will include development and delivery time. Additionally, we should consider any additional staffing requirements for backfilling positions during the training period. I suggest we collaborate on quantifying these elements, and we can also discuss any existing operational strain indicators, such as our current pharmacist overtime and technician vacancies, that might impact our ability to execute this plan effectively. What are your thoughts on gathering this data?
[R1.3] Hospital Finance & Operations Director (speak, public): I agree that gathering data on the total one-time costs for the training module and implementation is critical. Let's analyze the costs associated with developing and delivering the microlearning training for the 850 learners. We also need to assess any staffing backfills required during the training period, as well as review current operational strain indicators such as pharmacist overtime and technician vacancies. This comprehensive approach will help us understand the feasibility of the corrective action plan and its alignment with our patient safety and budget goals. How soon can we start collecting this data?

--- Round 2 ---
[R2.1] Quality & Patient Safety Director (speak, public): I appreciate everyone's commitment to gathering the necessary data on the costs and operational strain indicators. Let's set a timeline for collecting this information and ensure we have a follow-up meeting scheduled to discuss our findings. This will help us assess the feasibility of the corrective action plan effectively. How soon can we aim to have preliminary data ready for review?
[R2.2] Pharmacy Informatics Lead (speak, public): To ensure we are on track, I propose we aim to have preliminary data ready for review in one week. This will give us enough time to collect the necessary information on costs and operational strain indicators. We can then reconvene to discuss our findings and make informed decisions moving forward. Does this timeline work for everyone?
[R2.3] Hospital Finance & Operations Director (speak, public): I agree that a one-week timeline for gathering preliminary data is reasonable. Let's ensure we focus on both the costs associated with the training module and any operational strain indicators, including pharmacist overtime and technician vacancies. This will give us a strong foundation to assess the feasibility of the corrective action plan. I'll follow up with my team to expedite the cost analysis on our end. Looking forward to our next meeting to discuss the findings.

--- Round 3 ---
[R3.1] Quality & Patient Safety Director (speak, public): Thank you both for your commitment to this process. I agree that a one-week timeline is suitable for gathering the preliminary data. Let's prioritize our efforts to ensure we have a comprehensive overview of the costs and operational strain indicators. Once we have that data, we can reconvene to make informed decisions about the corrective action plan. I look forward to our next meeting and appreciate your collaboration on this critical initiative.
[R3.2] Pharmacy Informatics Lead (speak, public): I appreciate everyone's collaboration in gathering the necessary data. As we prepare for our next meeting, I will ensure my team compiles the training module costs and operational strain indicators efficiently. If there are any additional insights or data points you think we should consider, please feel free to share them as we move forward. Thank you!
[R3.3] Hospital Finance & Operations Director (leave, public): 

--- Round 4 ---
[R4.1] Quality & Patient Safety Director (leave, public): 
[R4.2] Pharmacy Informatics Lead (leave, public): 
[R4.3] Hospital Finance & Operations Director (leave, public): 

--- Round 5 ---
[R5.1] Quality & Patient Safety Director (leave, public): 
[R5.2] Pharmacy Informatics Lead (leave, public): 
[R5.3] Hospital Finance & Operations Director (leave, public): 

--- Round 6 ---
[R6.1] Quality & Patient Safety Director (leave, public): 
[R6.2] Pharmacy Informatics Lead (leave, public): 
[R6.3] Hospital Finance & Operations Director (leave, public): 

--- Round 7 ---
[R7.1] Quality & Patient Safety Director (leave, public): 
[R7.2] Pharmacy Informatics Lead (leave, public): 
[R7.3] Hospital Finance & Operations Director (leave, public): 

--- Round 8 ---
[R8.1] Quality & Patient Safety Director (leave, public): 
[R8.2] Pharmacy Informatics Lead (leave, public): 
[R8.3] Hospital Finance & Operations Director (leave, public): 

--- Round 9 ---
[R9.1] Quality & Patient Safety Director (leave, public): 
[R9.2] Pharmacy Informatics Lead (leave, public): 
[R9.3] Hospital Finance & Operations Director (leave, public): 

--- Round 10 ---
[R10.1] Quality & Patient Safety Director (leave, public): 
[R10.2] Pharmacy Informatics Lead (leave, public): 
[R10.3] Hospital Finance & Operations Director (leave, public): 

--- Round 11 ---
[R11.1] Quality & Patient Safety Director (leave, public): 
[R11.2] Pharmacy Informatics Lead (leave, public): 
[R11.3] Hospital Finance & Operations Director (leave, public): 

--- Round 12 ---
[R12.1] Quality & Patient Safety Director (leave, public): 
[R12.2] Pharmacy Informatics Lead (leave, public): 
[R12.3] Hospital Finance & Operations Director (leave, public): 

--- Round 13 ---
[R13.1] Quality & Patient Safety Director (leave, public): 
[R13.2] Pharmacy Informatics Lead (leave, public): 
[R13.3] Hospital Finance & Operations Director (leave, public): 

--- Round 14 ---
[R14.1] Quality & Patient Safety Director (leave, public): 
[R14.2] Pharmacy Informatics Lead (leave, public): 
[R14.3] Hospital Finance & Operations Director (leave, public): 

--- Round 15 ---
[R15.1] Quality & Patient Safety Director (leave, public): 
[R15.2] Pharmacy Informatics Lead (leave, public): 
[R15.3] Hospital Finance & Operations Director (leave, public): 

--- Round 16 ---
[R16.1] Quality & Patient Safety Director (leave, public): 
[R16.2] Pharmacy Informatics Lead (leave, public): 
[R16.3] Hospital Finance & Operations Director (leave, public): 

--- Round 17 ---
[R17.1] Quality & Patient Safety Director (leave, public): 
[R17.2] Pharmacy Informatics Lead (leave, public): 
[R17.3] Hospital Finance & Operations Director (leave, public): 

--- Round 18 ---
[R18.1] Quality & Patient Safety Director (leave, public): 
[R18.2] Pharmacy Informatics Lead (leave, public): 
[R18.3] Hospital Finance & Operations Director (leave, public): 

--- Round 19 ---
[R19.1] Quality & Patient Safety Director (leave, public): 
[R19.2] Pharmacy Informatics Lead (leave, public): 
[R19.3] Hospital Finance & Operations Director (leave, public): 

